COMBINATIONS OF A GLP1R AGONIST AND METFORMIN AND USE THEREOF FOR THE TREATMENT OF TYPE 2 DIABETES AND OTHER DISORDERS

The present invention provides uses of a glucagon-like peptide 1 receptor agonist in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, and improving the therapeutic effectiveness of metformin. The invention also provides pharmaceutical compositions that compr...

Full description

Saved in:
Bibliographic Details
Main Authors James C. QUADA, JR, Stephen Thomas DAVIS, Thomas Scott YOKUM, Adnan M.M. MJALLI, Maria Carmen VALCARCE LOPEZ, Dharma Rao POLISETTI, Bradley Alan CLARK, Robert Carl ANDREWS
Format Patent
LanguageEnglish
Spanish
Published 19.07.2019
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention provides uses of a glucagon-like peptide 1 receptor agonist in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, and improving the therapeutic effectiveness of metformin. The invention also provides pharmaceutical compositions that comprise a GLP1R agonist and metformin. La presente invención proporciona usos de un agonista del receptor de péptido 1 similar a glucagón, en combinación con metformina. Los usos incluyen tratar la diabetes tipo 2, reducir la glucosa sanguínea y mejorar la efectividad terapéutica de la metformina. La invención también proporciona composiciones farmacéuticas que comprenden un agonista de GLP1R y metformina.
Bibliography:Application Number: MX20150008555